This site is intended for healthcare professionals
News

FDA accepts BLA from Eisai and Biogen for aducanumab, a proposed treatment for Alzheimer’s disease.

Read time: 1 mins
Last updated:10th Aug 2020
Published:9th Aug 2020
Condition: Alzheimers
Type: drug
Register free for full access to medthority.com